Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 10 EP applications Anja Dietel-Manske has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after December 15, 2014). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP16848099

SALTS AND SOLID FORMS OF MONOBACTAM ANTIBIOTIC

IPC classification:
A61P 31/04, A61K 31/427, C07D 417/14
Applicant:
Novartis AG
Agent:
Weickmann & Weickmann PartmbB
Agent:
Anja Dietel-Manske, Novartis Pharma AG
Status:
Request for examination was made
EP16805218

DIAMINO PYRIDINE DERIVATIVES

IPC classification:
A61P 35/00, A61K 31/444, C07D 401/12
Applicant:
Novartis AG
Agent:
Anja Dietel-Manske, Novartis Pharma AG
Status:
Request for examination was made
EP16820359

INDANE DERIVATIVES AND THE USE THEREOF AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS

IPC classification:
C07D 401/12, C07D 401/10, C07D 401/14
Applicant:
Novartis AG
Agent:
Anja Dietel-Manske, Novartis Pharma AG
Status:
Request for examination was made
EP17704548

USE OF INHIBITORS OF THE ACTIVITY OR FUNCTION OF PI3K FOR THE TREATMENT OF PRIMARY SJÖGREN'S SYNDROME

IPC classification:
A61K 45/06, A61P 37/00, A61K 31/519
Applicant:
Novartis AG
Agent:
Nederlandsch Octrooibureau N.V.
Agent:
Anja Dietel-Manske, Novartis Pharma AG
Status:
Request for examination was made
EP16702207

GALENIC FORMULATION COMPRISING A TOPICAL DRUG

IPC classification:
A61K 47/32, A61K 9/06, A61K 9/00, A61K 38/12
Applicant:
Novartis AG
Agent:
Anja Dietel-Manske, Novartis Pharma AG
Status:
Request for examination was made
EP17711349

TRICYCLIC COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS

IPC classification:
A61P 31/16, A61K 31/5025, C07D 498/14, C07D 491/22, C07D 487/14, C07D 471/14
Applicant:
Novartis AG
Agent:
Carpmaels & Ransford LLP
Agent:
Anja Dietel-Manske, Novartis Pharma AG
Status:
Request for examination was made
EP17777966

COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF ENDOSOMAL TOLL-LIKE RECEPTORS

IPC classification:
A61P 37/00, A61K 31/437, C07D 471/04
Applicant:
Novartis AG
Agent:
Anja Dietel-Manske, Novartis Pharma AG
Status:
Request for examination was made
EP18188339

ANTIBODY DRUG CONJUGATES

IPC classification:
A61K 47/50, A61P 35/02, A61P 35/00, C07K 16/28
Applicant:
Novartis AG
Agent:
Anja Dietel-Manske, Novartis Pharma AG
Status:
The application has been published
EP17826574

NEW PICOLINIC ACID DERIVATIVES AND THEIR USE AS INTERMEDIATES

IPC classification:
C07D 213/81, C07D 213/79
Applicant:
Novartis AG
Agent:
Anja Dietel-Manske, Novartis Pharma AG
Status:
Request for examination was made
EP18209821

1,4-DISUBSTITUTED PYRIDAZINE ANALOGS AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS

IPC classification:
A61P 21/00, A61K 31/501, C07D 487/10, C07D 487/04, C07D 471/08, C07D 471/04, C07D 417/14, C07D 409/14, C07D 403/14, C07D 401/12, C07D 413/14, C07D 405/14, C07D 401/14
Applicant:
Novartis AG
Agent:
Anja Dietel-Manske, Novartis Pharma AG
Status:
The application has been published

Please Sign in to use this feature